Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President
FDA Approved Durvalumab Plus BCG for BCG-Naïve High-Risk NMIBC
President’s Cancer Panel Meeting Focused on Modifiable Cancer Risk Factors and Prevention Opportunities
Professor Richard Scolyer Dies at 59, Leaving a Legacy of Courage, Science and Cancer Innovation
Raymond Chan: Big News for Australian Science and Research
High PD-L1 Expression Linked To Shorter PFS With First-Line ALK TKIs In ALK-Rearranged NSCLC
Concert for Cures Series Surpasses $28 Million Raised for Cancer Research Following P!NK’s Electrifying Performance at Petco Park
Gender Representation in Radiation Oncology in Latin America
The Keystone Symposia conference titled "Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics" will take place from January 26–29, 2026, at the Embassy Suites by Hilton Raleigh Durham Research Triangle in Cary, North Carolina, United States. This meeting, organized by Scientific Organizers including Anwesha Dey, Laura D. Attardi, and Mariam Jamal-Hanjani, is […]
The Keystone Symposia conference, "Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations," will be held from March 15–18, 2026, at the Fairmont Le Château Frontenac in Québec City, Québec, Canada. This meeting brings together leading experts from academia, industry, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance, […]
The Keystone Symposia conference, "Tumor Microenvironment: Identifying Drivers of Progression and Resistance," will be held from May 17–20, 2026, at the Whistler Conference Centre in Whistler, British Columbia, Canada. This conference will explore the complex interactions between tumor cells and their surrounding microenvironment, focusing on identifying the tumor-intrinsic and extrinsic signaling programs that drive cancer […]
